We are live on ! Find out more
VCYT icon

Veracyte

292 hedge funds and large institutions have $2.78B invested in Veracyte in 2024 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 87 increasing their positions, 92 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

911% more call options, than puts

Call options by funds: $4.58M | Put options by funds: $453K

241% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 22

56% more capital invested

Capital invested by funds: $1.78B → $2.78B (+$1B)

22% more funds holding

Funds holding: 240292 (+52)

0.98% less ownership

Funds ownership: 107.44%106.45% (-0.98%)

5% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 92

Holders
292
Holders Change
+52
Holders Change %
+21.67%
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
75
Increased
87
Reduced
92
Closed
22
Calls
$4.58M
Puts
$453K
Net Calls
+$4.13M
Net Calls Change
+$3.58M

VCYT Hedge Fund Activity: Q3 2024 in Review

292 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2024, worth a combined $2.78B — up 56% from $1.78B a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new VCYT positions and 22 closed out — a net gain of 53 holders — while 87 added to existing stakes and 92 trimmed.

The largest buyer was Artisan Partners, adding an estimated $55.1M. The largest seller was Wellington Management Group, cutting an estimated $74.4M.

  • 292 institutional investors held Veracyte (VCYT) as of Q3 2024, up from 240 in Q2 2024.
  • Funds reported $2.78B of Veracyte stock for Q3 2024, up 56% quarter-over-quarter.
  • 75 funds opened new Veracyte positions in Q3 2024 and 22 closed out, a net change of +53 holders.
  • The largest Veracyte buyer in Q3 2024 was Artisan Partners, an estimated $55.1M added.
  • The largest Veracyte seller in Q3 2024 was Wellington Management Group, an estimated $74.4M sold.

Based on aggregated 13F filings for Q3 2024.